ストックスクリーナーアプリを入手
258.31
0.27%
0.70
Resmed Inc (RMD) 最新ニュース
ResMed Inc. $RMD Shares Acquired by Keybank National Association OH - MarketBeat
ResMed: Facing A Potentially Dream-Disrupting DoseStrong Sell - Seeking Alpha
ResMed outlines 62%–63% gross margin target for fiscal 2026 amid double-digit growth in key segments - MSN
ResMed Reaffirms 2025 Risk Profile: No Material Changes to Previously Disclosed Threats - TipRanks
Is Federal Agricultural Mortgage Corporation stock trending bullishGap Down & Technical Pattern Based Buy Signals - baoquankhu1.vn
ResMed Inc Earnings Call Shows Profitable Growth Momentum - TipRanks
RMD Q4 Deep Dive: Mask Innovation and Digital Health Expansion Drive Growth - Finviz
Breaking Down ResMed: 7 Analysts Share Their Views - Benzinga
ResMed’s Profitability Surge Driven by Operational Excellence - AD HOC NEWS
Explore ResMed Market Coverage and Healthcare Sector Context - Kalkine Media
Analysts Maintain Bull Case On ResMed Despite Competition Concerns - Benzinga
Resmed Q2: Mask sales surge as new products, resupply gain traction | - HME News
ResMed stock price target raised to $314 from $311 at RBC Capital By Investing.com - Investing.com South Africa
Wells Fargo & Company Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock - MarketBeat
Wells Fargo Analyst Raises ResMed (RMD) Price Target to $270 | R - GuruFocus
ResMed Inc. (NYSE:RMD) Declares Quarterly Dividend of $0.60 - MarketBeat
ResMed stock price target raised to $314 from $311 at RBC Capital - Investing.com Nigeria
KeyBanc raises ResMed stock price target to $302 on solid revenue beat - Investing.com
Wolfe Adjusts Price Target on ResMed to $230 From $225, Maintains Underperform Rating - marketscreener.com
KeyBanc Adjusts Price Target on ResMed to $302 From $299, Maintains Overweight Rating - marketscreener.com
Stifel Adjusts Price Target on ResMed to $265 From $260, Maintains Hold Rating - marketscreener.com
Resmed posts Street-beating Q2 results amid increased CPAP demand - MassDevice
Piper Sandler Adjusts Price Target on ResMed to $275 From $270, Maintains Neutral Rating - marketscreener.com
ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript - Insider Monkey
ResMed stock holds steady as Needham reiterates Hold rating By Investing.com - Investing.com Nigeria
ResMed stock holds steady as Needham reiterates Hold rating - Investing.com
Meridian Management Co. Buys Shares of 9,221 ResMed Inc. $RMD - MarketBeat
Pittenger & Anderson Inc. Has $26.81 Million Stock Holdings in ResMed Inc. $RMD - MarketBeat
Medical device maker ResMed rises on Q2 profit beat - TradingView
ResMed's Moat Is Underpinned by Switching Costs and Intangible Brand Assets - Morningstar
Tandem Investment Advisors Inc. Grows Stock Holdings in ResMed Inc. $RMD - MarketBeat
Why ResMed’s Hot Streak Has Investors Turning Cautious - TipRanks
RESMED INC SEC 10-Q Report - TradingView
ResMed (NYSE: RMD) grows revenue 11% and lifts margins in latest quarter - Stock Titan
ResMed Founder’s Horatio Alger Honor And What It Means For Investors - simplywall.st
ResMed (RMD) Maintains Quarterly Dividend of $0.60 Per Share - GuruFocus
AlphaQuest LLC Grows Stock Position in ResMed Inc. $RMD - MarketBeat
Horatio Alger Honor Puts ResMed Leadership And Growth Story In Focus - Yahoo Finance UK
ResMed Q2 Earnings Call Highlights - MarketBeat
ResMed Inc (RMD) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
Ozempic-style drugs prove to be 'a tailwind' for Resmed - aapnews.aap.com.au
Stock of the day: ResMed - ig.com
ResMed shares slip after Q2 FY26 results release - AlphaStreet
ResMed Q2 FY26 presentation: Revenue up 9%, expanding margins amid digital health push - Investing.com Nigeria
ResMed’s Q2 margins keep climbing, while valuation sits below history - Market Index
Hot Stocks: ResMed, Etherstack, Chilwa Minerals, 4DMedical - Sharecafe
ResMed Shares Surge After Positive Results - Sharecafe
ResMed Q2 FY26 presentation: Revenue up 9%, expanding margins amid digital health push By Investing.com - Investing.com South Africa
Why 4DMedical, Appen, Nine Entertainment, and ResMed shares are storming higher today - The Motley Fool Australia
Stocks making the biggest moves at noon: Appen, ResMed, energy stocks and more - Market Index
ResMed (RMD.AX ASX) Q2 beats lift A$36.82 intraday 30 Jan 2026: watch margins - Meyka
Why is the ResMed share price jumping 7% today? - The Motley Fool Australia
ResMed Exceeds Expectations With Strong Q2 Results - Sharecafe
ResMed beats quarterly profit estimates on strong demand for its sleep devices - TradingView
ResMed Inc (NYSE:RMD) Beats Q2 Earnings Estimates on Strong Margin Expansion - Chartmill
Earnings call transcript: ResMed beats Q2 2026 EPS forecast, stock dips - Investing.com
ResMed’s Sleep Apnea Sales Kept Beating Expectations - Finimize
ResMed (NYSE:RMD) Exceeds Q4 CY2025 Expectations - Finviz
Resmed (RMD) Surpasses Revenue Expectations in Q2 - GuruFocus
ResMed (RMD) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
ASX 200 LIVE updates: Apple first quarter results beat estimates; Resmed reports 11% headline revenue growth - AFR
Resmed posts Q2 FY26 earnings growth, lifts dividend - The Motley Fool Australia
ResMed shares rise 2% as Q2 earnings top estimates, margins improve - Investing.com UK
ResMed shares rise 2% as Q2 earnings top estimates, margins improve By Investing.com - Investing.com Nigeria
1.07%
0.21%
大文字化:
|
ボリューム (24 時間):